ÀÛ¼ºÀÏ : 25-11-10 11:16
|
.....
|
|
|
±Û¾´ÀÌ :
111
 Á¶È¸ : 7
|
TADACIP-20 éçÓð¡¸ÚúÑÃò¥áÙΦÎù£¨Priapism£©¡¹怎麼ô¥×⣿
î¤Ñûàõð¾Úúå·ã¼íÞñ飬ìÔÓøßù××ÞÍ TADACIP-20£¨öâÓ¹ÕÃÞª Tadalafil 20mg£© ãÀë¦ìÔÓøð²å·ËÝÔé Cipla Ltd. õóù¡îÜÍÔù¡òõùÊ٣巡£îÏγ TADACIP-20 ìÔÓøßù××ÞÍùÊÙ£å· ì¤è±ïÒå·üù¡¢öááÜÑÃüùæ¨Ê¦ò¥áÙ 36 á³ãÁîÜ¡¸íþüùð¾ÚúÕô¡¹Ú¤Ù££¬à÷為úÉÒýÑûàõËÇà¼ÚúÑÃÍíÒöî¡礙£¨ED£©îÜâÏàÔ¡£
æÔ컣¬î¤Ý»ÝÂï×üÏù»£¬Ü×éÄ TADACIP-20 ýʦÒöõóúÞùÖ̸ӣåññìîÜÜùíÂéÄ——ÚúÑÃò¥áÙΦÎù£¨Priapism£©¡£ÜâÙþíâÌ¿ùêì¢ùÊ研ϼâ¦Ëàæ¨×üßÉÌèúУ¬ßÙá¬ú°à°îÏìéúÞßÚîÜê«ìס¢êËúÏàõæ¨ëëÓßÛ°ãÒ£¬幫ð¾ÞÅéÄíºäÌîïÞÅéÄ TADACIP-20 öâÓ¹ÕÃÞªùÊÙ£
ìé¡¢ä§麼ãÀ¡¸ÚúÑÃò¥áÙΦÎù£¨Priapism£©¡¹£¿
ÐÆËàÚ¸ÏÐù²ÒãΡì¢ùÊü壨AUA£©îÜïÒëù£¬Priapism£¨ò¥áÙàõÚúÑÃñø£© ãÀò¦ëäÌìî¤Ú±áôÓðàõí©Ìù»í¤ò¥áÙÚúÑÃõ±Î¦ 4 á³ãÁì¤ß¾£¬ó¦ÙíÛöí»æÔá¼÷ÜîÜï×üÏ¡£îÏãÀ TADACIP-20 ÜùíÂéÄ ñéпá´Ì¸Ó£âÍØ¡即ô¥×âîÜìéðúßÒüÏ¡£
×üßÉ߾ʦÝÂ為Õ××¾£º
ÌÀúìàõ Priapism£¨Ischemic£©£º佔á¶êóÜ»ÖÇå³ 95%£¬為ì¢ÖûÐáñø¡£ëäÌìúØúô÷úìäûôò׺¡¢ÌÀ氧£¬å´õ±Î¦ 6 á³ãÁüåÓôöÈðÚòÄÎÕÞÝ¡£
ÞªÌÀúìàõ Priapism£¨Non-ischemic£©£º÷×ßÈì×úìηóÜß¿ûäèâÕôÓôöÈ£¬âÌÜôêËÐàßæÙ¤£¬Ó£í¤âÍì¢ÞÔøÄ估¡£
ÐÆËà Journal of Urology (2018) ÜÃÓô£¬å´ÚúÑÃò¥áÙõ±Î¦ 24 á³ãÁÚ±ö½Öû£¬90% ì¤ß¾ü´íºüåõóúÞçµÎùàõÚúÑÃÍíÒöî¡礙¡£
죡¢為ù¼Ü×éÄ TADACIP-20 üåõóúÞ Priapism£¿
TADACIP-20 îÜà÷ÝÂ為 öâÓ¹ÕÃÞª£¨Tadalafil£©£¬áÕåÚ PDE5 åäð¤ð¥£¨Phosphodiesterase type-5 inhibitor£©¡£它ÒöÛ¯鬆ëäÌìúØúô÷øÁüÁÑ¿¡¢õµòäúìäû×µìý£¬Ó¹Óðò¥ÎùÚúÑÃîÜüùÍý¡£
Ó£î¤Ù»ÞÁ÷åâ¨ßÒüÏù»£¬å·üùΦ強ûäÓÛÞóì¶ßÈʦÒöÓôöÈúìäûÙíÛöïáßÈüÞ×µ£¬û¡à÷ëäÌìúì×µôò׺¡£
ßÈ̸îÜë¯Û¡ê«ì×øÐÎÀ£º
TADACIP-20 ð¥ÕáΦÍÔ£¨õ±Î¦ØßìíËïì¡ 20mg£©
ÔÒãÁÞÅéÄÐìöâð¾Úúå·£¨åý Super P-Force¡¢Sildenafil¡¢Levitra£©
飲ñÐûäÞÅéÄÔ¸ù¡£¨÷åܬãÀʦ卡ìס¢äÌÞªöâÙ¤£©
ü´êóúìäûòðÜ»£¨åý鐮ßÒá¬øàÞ¸úì¡¢ÛÜúìÜ»£©
ÊÜãìÍíÒöáôáßÓôöÈå·ÚªÓÛÞóܨط
ÐÆËà European Urology (2020) 研ϼ£¬Ü×éÄ PDE5 åäð¤ð¥ýõóúÞ Priapism îÜѦáãá³åÚ 0.1%£¬Ó£å´ùê併úìäûòðÜ»ûäÕ½éÄå·Úª£¬ù¦úÏʦÒö߾㮠5~10 Ûá£
ß²¡¢ÚúÑÃΦÎùîÜêËúÏàõ
å´ÞÅéÄ TADACIP-20 ìÔÓøßù××ÞÍùÊÙ£å· ýõóúÞÚúÑÃõ±Î¦ 4 á³ãÁÚ±á¼÷Ü£¬ëäÌìÒ®úìäûì×ÌÀ氧üåðãà÷£º
мÖÔÙ÷Ôæ¨ðþóì
ëäÌìðÚòÄÌÀúìÎÕÞÝ
çµÎùàõÚúÑÃÍíÒöî¡礙£¨ED£©
åññìãÁâÍòäú¼èâΡâ¢âú
American Journal of Emergency Medicine (2021) ÜÃͱò¦õó£º
å´î¤ 6 á³ãÁÒ®ö½Öû Priapism£¬ü´íºèÇîïüáÜÖÚúÑÃÍíÒöîÜÝïÖÇÍÔÓ¹ 77%£»å´õ±Î¦ 24 á³ãÁÚ±ô¥×⣬üáÜÖáãÐÁí¥ 25%¡£
ÞÌ¡¢Û¡ß桸ÚúÑÃò¥áÙΦÎù¡¹ãÁîÜïáü¬ô¥×âÛ°ãÒ
å´Ü×éÄ TADACIP-20 öâÓ¹ÕÃÞªùÊÙ£å· ýõóúÞíþãÁÊàÚúÑã¬ôëØ¡即óõö¢ì¤ù»ÜÆö®£º
ïÎòá¶êóàõí©Ìæ¨ê¡ÔÑ£¬ÜÁò¥ÕÒð¡¡£
ÞÅéÄ冰ݧëäÌìÐÆÝ»£¨Øßó 10~15 ÝÂñ¤£©£¬êóð¾úìηâ¥õê¡£
ùØóí»ú¼Ü×éÄò÷Ôå·ûä˽äâå·£¬ì¤ØóåóËÏÜ»ïס£
å´ÚúÑÃò¥áÙõ±Î¦ 4 á³ãÁ£¬ëëØ¡即ö¦ì¢¡£
î¤ì¢ê£¬ù²ÒãΡì¢ÞÔʦÒöóõéÄì¤ù»ö½ÖûÛ°ãÒ£º
ëäÌìõÎúìÊõä⣨Aspiration therapy£©£ºõÎõóôò׺úìäûì¤Ë½î¸äâÕô¡£
ÏÑÝ»ñ¼ÞÒËÛ氧ãìß¾àÍáÈ£¨Phenylephrine£©£ºõµòäúìηâ¥õê¡£
â¢âúìÚ×µ£¨Shunt operation£©£ºöÜÓßåññìûäÚãÜÝàõÜ»ÖÇ¡£
çé¡¢åýù¼çèÛÁ TADACIP-20 ìÚÛ¡ Priapism
為ùØóó®×¾ÜùíÂéÄî¢óÛ¡ßæ£¬Ëïì¡ÞÅéÄíºñåáúì¤ù»ê«öΣº
åñÌ«ñåáú TADACIP-20 ð¥Õ᣺ØßìíùÚÜ×ìéó¡£
ùØóæ¨Ðìöâð¾Úúå·ÚªûäñÐïñ併éÄ¡£
âÏóÞÅéÄʦà»ðô TADACIP-10mg ËÒã·ÎºóÌÚãëë¡£
ü´êóØ·àõòðÜ»íº£¨åýÓØÒãÜ»¡¢ÍÔúìä⣩âÍÞÀà»í¿âóì¢ÞÔ¡£
ÜÁò¥ÕÞû¿ßæüÀã§Î±£ºÐ®×Èê¡ÔÑ¡¢ùØóè¢å¨æ¨ýå菸¡£
ÐÆËà Cipla ð²å·×üßÉíÀÖù£¨2022£©£¬î¤ñåáúì¢ÞÔò¦ãÆÜ×éÄîÜðéÏØñé£¬Û¡ßæÚúÑÃΦÎùûäåññìÜùíÂéÄîÜÝïÖÇî¸åÚ 0.05%¡£
׿¡¢õÅÌ¿£ºäÌîïÞÅéÄ TADACIP-20£¬ü¬ÜÁàõËíˬ
TADACIP-20£¨öâÓ¹ÕÃÞª 20mg£© ãÀìéγÍÔüù¡¢ò¥Îùó¦äÌîïàõÍÔîÜ ìÔÓøßù××ÞÍùÊ٣巣¬Ó£å´ÞÅéÄÜôÓ×í¤Ê¦ÒöÓôöÈ Priapism£¨ÚúÑÃò¥áÙΦÎù£©¡£
Ó×õóúÞõ±Î¦ 4 á³ãÁÜô÷ÜîÜÚúÑÃãÁ£¬Ùâù±ãÊ為ì¢ÖûÐáñø£¬ò×öáãüÏ´ù²ÒãΡúð𾡣
ïáü¬ð¥ÕáÍó𤡢ì¢ÞÔò¦Óôæ¨äÌîïëòãÛ£¬ãÀü¬ÜÁ TADACIP-20 ð¾Úúå· Û¡ýÆõÌÊ¢üùÍýîÜμËõ¡£
ßÓμ產ù¡õÏôÀ£ºÑÑóÈõ±ÐääõÕôÓ¹äªüùø¸ ÓìÏÐûõتêÎÌ«Õã¨VIGORA £©â©ÍýÚ«Ï¢éÁïüêÎ 100mg ïáù¡úÅùûÖÕñéì¢ ìÔÓøâíòäÏ¢ïáù¡ù±××ÌÍPriligy(POXET-60)GOODMANëäÌìñòÓÞü¯goodmanÚ¸ÏÐßù××ÞÍCialisê«íûòäÏ¢áÜüùð¾Úú
æÅãßæóÔÁ£ºTadacip-20 ÞÅéÄæ¨ãýúìηå·ÚªÎßû»íÂéÄ
|
|